- Home
- BBCP vs PRQR Comparison
BBCP vs PRQR Comparison
Compare BBCP & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- PRQR
- Stock Information
- Founded
- BBCP 1983
- PRQR 2012
- Country
- BBCP United States
- PRQR Netherlands
- Employees
- BBCP N/A
- PRQR N/A
- Industry
- BBCP Engineering & Construction
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- BBCP Consumer Discretionary
- PRQR Health Care
- Exchange
- BBCP Nasdaq
- PRQR Nasdaq
- Market Cap
- BBCP 302.4M
- PRQR 309.5M
- IPO Year
- BBCP 2017
- PRQR 2014
- Fundamental
- Price
- BBCP $6.04
- PRQR $1.37
- Analyst Decision
- BBCP Buy
- PRQR Strong Buy
- Analyst Count
- BBCP 4
- PRQR 6
- Target Price
- BBCP $7.83
- PRQR $8.50
- AVG Volume (30 Days)
- BBCP 198.9K
- PRQR 638.6K
- Earning Date
- BBCP 06-05-2025
- PRQR 05-08-2025
- Dividend Yield
- BBCP N/A
- PRQR N/A
- EPS Growth
- BBCP N/A
- PRQR N/A
- EPS
- BBCP 0.28
- PRQR N/A
- Revenue
- BBCP $414,608,000.00
- PRQR $20,235,014.00
- Revenue This Year
- BBCP N/A
- PRQR $6.44
- Revenue Next Year
- BBCP $6.18
- PRQR N/A
- P/E Ratio
- BBCP $21.34
- PRQR N/A
- Revenue Growth
- BBCP N/A
- PRQR 196.41
- 52 Week Low
- BBCP $4.78
- PRQR $1.07
- 52 Week High
- BBCP $9.68
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- BBCP 54.12
- PRQR 48.87
- Support Level
- BBCP $5.10
- PRQR $1.10
- Resistance Level
- BBCP $6.26
- PRQR $1.26
- Average True Range (ATR)
- BBCP 0.31
- PRQR 0.14
- MACD
- BBCP 0.10
- PRQR 0.05
- Stochastic Oscillator
- BBCP 81.03
- PRQR 96.97
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.